Theralase Technologies Inc. V.TLT

Price Range

[james700]

If no approval or bankrupt most likely ZERO. 
LET'S face it Theralase currently does not make a profit and has taken on debt.  The timeline to get approved is not infinite, as other solutions will come to market. 

However, the cancer treatment and the potential anti-microbial benefits of Ruthenium based compounds have a chance to succeed and come to market. 

NMIBC treatment might be worth $1B, $2B, $4B or fully valued $8B depending on what stage TLT gets to before striking a deal.  The cash burn would suggest that a deal sooner than later is in order. So, I would guess $2B might be more likely than $8B. Unless, there is a bidding war after BTD approval.

Present market cap is only $38M so you just have to do the math. 

1,000/38 = 26 times current price. 
2,000/38 = 52 times current price 
4,000/38 = 104 times current price 
8,000/38 = 208 times current price

[Legit62]

Very very unlikely scenerio we go bankrupt at this stage with the money Roger has personally invested, my thought is we get BTD announcement at or near AGM, worse case scenerio is we take JV sooner than we want, this stock heading over $10 within short time frame thats how close we are. Too many indications and with upcoming vaccine and other indications it will become bidding buyout

[menoalittle]

BTD is not going to be the next news announcement that moves this stock significantly higher... but, what do I know...

[Legit62]

We become a legitamate player with BTD, from minors to majors but not playoff yet,AA and fda approval will set us free

[O12009]

It seems that you are think about something ,maybe you know a little. How about sharing your thoughts.

[managementfirst]

I pray you said come true in time.

[skys1]

james700 - I don't know where you get your information, but I suggest you find another source. You claim TLT has taken on debt. WRONG, TLT has no debt. NONE as in ZERO DEBT!

[james700]

I believe they owed $386k in 2022.